drug

Plasma Exchange

MeSH D010951
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BIOLOGICAL
Pre-approval / investigational in the US
Developed by University of Cambridge
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BIOLOGICAL

Indications

Trials

1
Study of Immunotherapy in Autoantibody Positive Psychosis
NCT02449746—Completed

KOLs & investigators

1
Alasdair Coles, 01223 762016

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Cambridge
company
trial
Study of Immunotherapy in Autoantibody Positive Psychosis
NA
trial
indication
Schizophrenia
indication
Psychological Well-Being
indication
Psychosis
indication
Auto Immune Disorders
indication
KOL
Alasdair Coles, 01223 762016
KOL score —
person